Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Effect of glutathione and Y27632 on the viability of cryopreserved porcine adipose-derived stem cells.

Qu CQ., Li DW., Shen N., Jiang-Yang JH., Ji YT.

Animal Study, published in Cryo Letters (2014) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Cryo Letters (2014)
Country
England
Reported sample size
—
Source database
PubMed
PMID
25282498
Citations
1

Abstract (original English)

Background Recently it has been reported that reduced glutathione (GSH) and/or Rho-associated kinase (ROCK) inhibitor supplemented in cryopreservation solution could improve the viability of cells. Objective To identify the cryopreservation efficiency of GSH and ROCK inhibitor on porcine ADSCs. Materials and methods Porcine ADSCs were separated and cultured. Cells at the 4th passage were suspended in cryopreservation solution supplemented with Y-27632 and GSH or both, and then frozen and thawed. The viability of cryopreserved ADSCs was compared using a MTT assay. Results The addition of GSH and Y-27632 to cryopreservation solution (dimethyl sulfoxide) and post-thaw culture medium significantly improves the post-thaw viability of ADSCs. Conclusion GSH and Y-27632 are able to increase the survival of ADSCs, and they have an additive effect, as compared to GSH or Y27632 alone.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAmidesAnimalsCell SeparationCell SurvivalCryopreservationCryoprotective AgentsDimethyl SulfoxideEnzyme InhibitorsGlutathione

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.